Parstatin suppresses ocular neovascularization and inflammation.
about
Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eyeAnti-Parstatin Promotes Angiogenesis and Ameliorates Left Ventricular Dysfunction during Pressure Overload.Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administration.The protease-activated receptor 1 possesses a functional and cleavable signal peptide which is necessary for receptor expression.
P2860
Parstatin suppresses ocular neovascularization and inflammation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Parstatin suppresses ocular neovascularization and inflammation.
@ast
Parstatin suppresses ocular neovascularization and inflammation.
@en
type
label
Parstatin suppresses ocular neovascularization and inflammation.
@ast
Parstatin suppresses ocular neovascularization and inflammation.
@en
prefLabel
Parstatin suppresses ocular neovascularization and inflammation.
@ast
Parstatin suppresses ocular neovascularization and inflammation.
@en
P2093
P2860
P356
P1476
Parstatin suppresses ocular neovascularization and inflammation.
@en
P2093
Helen Papadaki
Ji-Kui Shen
Katerina Geronatsiou
Michael E Maragoudakis
Nikos E Tsopanoglou
Panagiotis Vasilakis
Sotirios P Gartaganis
Stanley A Vinores
Xiufeng Zhong
P2860
P304
P356
10.1167/IOVS.10-5576
P407
P577
2010-06-10T00:00:00Z